Safe Administration of SARS-CoV-2 Vaccine After Desensitization to a Biologic Containing Polysorbate 80 in a Patient With Polyethylene Glycol-Induced Severe Anaphylaxis and Sensitization to Polysorbate 80
- PMID: 35638393
- DOI: 10.18176/jiaci.0830
Safe Administration of SARS-CoV-2 Vaccine After Desensitization to a Biologic Containing Polysorbate 80 in a Patient With Polyethylene Glycol-Induced Severe Anaphylaxis and Sensitization to Polysorbate 80
Keywords: Allergy; Desensitization; Infliximab; Polyethylene glycol; Polysorbates; SARS-CoV-2 vaccine.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous